Dipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host Disease-Reference-Cited by-同舟云学术

Dipeptidyl Peptidase 4 Inhibition for Prophylaxis of Acute Graft-versus-Host Disease

Published:2021-01-07 Issue:1 Volume:384 Page:11-19
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Farag Sherif S.¹,Abu Zaid Mohammad¹,Schwartz Jennifer E.¹,Thakrar Teresa C.¹,Blakley Ann J.¹,Abonour Rafat¹,Robertson Michael J.¹,Broxmeyer Hal E.¹,Zhang Shuhong¹

Affiliation:

1. From the Indiana University School of Medicine (S.S.F., M.A.Z., J.E.S., R.A., M.J.R., H.E.B., S.Z.), Indiana University Health (S.S.F., M.A.Z., J.E.S., T.C.T., R.A., M.J.R.), and Indiana University Simon Comprehensive Cancer Center (S.S.F., A.J.B., H.E.B.) — all in Indianapolis.

Funder

National Heart, Lung, and Blood Institute

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2027372

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modern views of nutritional support in patients undergoing allogeneic stem cell transplantation;Clinical Nutrition ESPEN;2024-10

2. Sitagliptin is a time-tested leading drug in the treatment of type 2 diabetes;Meditsinskiy sovet = Medical Council;2024-09-02

3. Effects of dipeptidyl peptidase‐4 inhibition in vivo: Dipeptidyl peptidase‐4 inhibitor/gut microbiome crosstalk suggests novel therapeutic options for diabetes management;Journal of Diabetes Investigation;2024-02-07

4. Janus kinase inhibition in the treatment and prevention of graft-versus-host disease;Frontiers in Immunology;2024-02-06

5. A phase 2 trial of CD24Fc for prevention of graft-versus-host disease;Blood;2024-01-04